Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-072200
Filing Date
2022-11-14
Accepted
2022-11-14 16:09:34
Documents
64
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_chinapharma.htm   iXBRL 10-Q 553177
2 CERTIFICATION f10q0922ex31-1_chinapharma.htm EX-31.1 9967
3 CERTIFICATION f10q0922ex31-2_chinapharma.htm EX-31.2 10530
4 CERTIFICATION f10q0922ex32-1_chinapharma.htm EX-32.1 5889
  Complete submission text file 0001213900-22-072200.txt   3636366

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20220930.xsd EX-101.SCH 49314
6 XBRL CALCULATION FILE cphi-20220930_cal.xml EX-101.CAL 41224
7 XBRL DEFINITION FILE cphi-20220930_def.xml EX-101.DEF 192240
8 XBRL LABEL FILE cphi-20220930_lab.xml EX-101.LAB 389040
9 XBRL PRESENTATION FILE cphi-20220930_pre.xml EX-101.PRE 203559
58 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_chinapharma_htm.xml XML 318973
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 221385246
SIC: 2834 Pharmaceutical Preparations